Skip to content

A study to see how combining muscle stimulation and breathing exercises helps improve walking ability and reduces shortness of breath in people with chronic lung disease (COPD)

Effect Of Neuromuscular Electrical Stimulation Combined With Inspiratory Muscle Training On Dyspnea, Quality Of Life and Exercise Capacity In Patients With Chronic Obstructive Pulmonary Disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106758
Enrollment
180
Registered
2026-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: Neuromuscular Electrical Stimulation (NMES) combined with Inspiratory Muscle Training (IMT).: Intervention (Group A)Description: Subjects will receive both Neuromuscular Electrical Stim

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with a confirmed diagnosis of Chronic Obstructive Pulmonary Disease, as evidenced by Forced expiratory volume in one second less than eighty percent predicted and a ratio of Forced expiratory volume in one second to Forced vital capacity of less than seventy percent. 2.Participants age between 18-75 years. 3.Patient must have clinically stable COPD, with no exacerbations requiring hospitalization or changes in maintenance medication within the past four weeks. 4.Patient must not have metal implants, such as cardiac pacemakers or prosthetics. 5.Patient must have normal intelligence and no communication barriers. 6.Patient must be willing to participate in the study and provide informed consent

Exclusion criteria

Exclusion criteria: 1.Patient with any cardiovascular, neuromuscular diseases, malignant tumors, metabolic diseases will be excluded. 2.Patient with diagnosed psychiatric or cognitive disorders will be excluded. 3.Patient with severe orthopedic problems that significantly impact daily activities will be excluded. 4.Patient with prior inclusion in a pulmonary rehabilitation program will be excluded.

Design outcomes

Primary

MeasureTime frame
6-minute walk test (6MWT). The modified Medical Research Council (mMRC) dyspnea scale St George s Respiratory Questionnaire (SGRQ). COPD Assessment Test (CAT) Timepoint: Baseline and at the completion of eight weeks of intervention

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactMegha Arya

Galgotias University

singh.nidhi@galgotiasuniversity.edu.in7042627025

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026